Pontifax VC

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.